Simple Blood Test Could Soon Diagnose Five Deadly Cancers At Once, National Human Genome Research Institute Study
Scientists in the US have identified a common genomic signature in tumour DNA that is shared by five different kinds of cancer. The finding could lead to the development of a simple blood test that might be able to diagnose a variety of cancers at early stages.
This telltale signature results from a chemical modification of DNA called methylation, which controls the expression of genes. Having identified this methylation biomarker, the scientists uncovered consistent evidence of it in five different kinds of tumours: colon, lung, breast, stomach, and endometrial cancers.
This telltale signature results from a chemical modification of DNA called methylation, which controls the expression of genes. Having identified this methylation biomarker, the scientists uncovered consistent evidence of it in five different kinds of tumours: colon, lung, breast, stomach, and endometrial cancers.